This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that
manifests under diverse and divergent circumstances. We begin with a historical …

Kaposi sarcoma (KS) is the most common cancer in people living with HIV (PLWH) in many
countries where KS‐associated herpesvirus is endemic. Treatment has changed little in 20 …

Highlights•T cell responses to KSHV are diverse and weak compared to other
herpesviruses.•CD8+ T cells in KS tumours are localised to regions that are KSHV LANA …

Kaposi's sarcoma herpesvirus (KSHV) establishes lifelong infection and persists in latently
infected B cells. Paradoxically, in vitro B cell infection is inefficient, and cells rapidly die …

BACKGROUND Kaposi sarcoma (KS) is among the most common childhood cancers in
Eastern and Central Africa. Pediatric KS has a distinctive clinical presentation compared …

Kaposi sarcoma (KS)-associated herpesvirus (KSHV/HHV-8) was first sequenced from the
body cavity (BC) lymphoma cell line, BC-1, in 1996. Few other KSHV genomes have been …

Infection by Kaposi sarcoma-associated herpesvirus (KSHV) can cause severe
consequences, such as cancers and lymphoproliferative diseases. Whole inactivated …

ABSTRACT “When you can measure what you are speaking about, and express it in
numbers, you know something about it.” is a famous quote attributed to Lord Kelvin. This …

Background To determine the pattern of immune cell subsets across the life span in rural
sub-Saharan Africa (SSA), and to set a reference standard for cell subsets amongst Africans …

Background We identified whether maternal human immunodeficiency virus (HIV) infection
during pregnancy affects transplacental transfer of Kaposi sarcoma-associated herpesvirus …